Brain dopamine transporter messenger RNA and binding sites in cocaine users: A postmortem study

Archives of General Psychiatry

Volumn 55, Issue 9, 1998, Pages 793-799

  Little, Karley Y ^a,b   McLaughlin, Daniel P ^c   Zhang, Lian ^a   McFinton, Patrick R ^a   Dalack, Gregory W ^a,b   Cook Jr , Edwin H ^d   Cassin, Bader J ^e   Watson, Stanley J ^a,c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e Office of the Wayne County Medical Examiner   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DOPAMINE TRANSPORTER; MESSENGER RNA; RADIOLIGAND;

ADULT; ARTICLE; AUTOPSY; AUTORADIOGRAPHY; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION FUNCTION; DRUG ABUSE; DRUG BINDING SITE; DRUG EXPOSURE; FEMALE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LIGAND BINDING; MALE; QUANTITATIVE ASSAY;

ADULT; ANIMALS; AUTORADIOGRAPHY; BINDING SITES; BRAIN CHEMISTRY; CARRIER PROTEINS; COCAINE-RELATED DISORDERS; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; IN SITU HYBRIDIZATION; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; RATS; RNA, MESSENGER;

EID: 0031693772     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.55.9.793     Document Type: Article

References (34)

1. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science. 1987;237:1219-1223.
2. Weiss F, Hurd YL, Ungerstedt U, Markou A, Plotsky PM, Koob G. Neurochemical correlates of cocaine and ethanol self-administration. Ann N Y Acad Sci. 1992; 654:220-241.
3. Goeders NA, Smith JE. Cortical dopaminergic involvement in cocaine reinforcement. Science. 1983;221773-775.
4. 3H]WIN 35428 binding sites in human striatum. Brain Res. 1993;628:17-25.
5. Staley JK, Hearn L, Ruttenber J, Wetli CV, Mash DC. High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims. J Pharmacol Exp Ther. 1994;271:1678-1685.
6. Hurd Y, Herkenham M. Molecular alterations in the neostriatum of human cocaine addicts. Synapse. 1993;13:357-369.
7. Wilson JM, Levey AI, Bergeron C, Kalasinsky K, Ang L, Peretti F, Adams VI, Smialek J, Anderson WR, Shannak K, Deck J, Niznik HB, Kish SJ. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users. Ann Neurol. 1996;40:428-439.
8. 3H-GBR 12,935 are differentially regulated by chronic cocaine self-administration. J Neurosci. 1994;14(5 pt 2):2966-2979.
9. Koff JM, Shuster L, Miller LG. Chronic cocaine administration is associated with behavioral sensitization and time-dependent changes in striatal dopamine transporter binding. J Pharmacol Exp Ther. 1994;268:277-282.
10. Hitri A, Little KY, Ellinwood EH. Effect of cocaine on dopamine transporter receptors depends on routes of chronic cocaine administration. Neuropsychopharmacology. 1996;14:205-210.
11. Alburges ME, Narang N, Wamsley JK. Changes in the dopaminergic receptor system after chronic administration of cocaine. Synapse. 1993;14:314-323.
12. Pilotte NS, Sharpe LG, Kuhar MJ. Withdrawal of repeated intravenous infusion of cocaine persistently reduces binding to dopamine transporters in the nucleus accumbens of Lewis rats. J Pharmacol Exp Ther. 1994;269:963-969.
13. Peris J, Boyson SJ, Cass WA, Curella P, Dwoskin LP, Larson G, Lin LH, Yasuda RP, Zahniser NR. Persistence of neurochemical changes in dopamine systems after repeated cocaine administration. J Pharmacol Exp Ther. 1990;254:38-44.
14. 3H] mazindol-labelling of dopamine transporter in rat nucleus accumbens. Eur J Pharmacol. 1991;203:141-144.
15. Kula NS, Baldessarini RJ. Lack of increase in dopamine transporter binding or function in rat brain tissue after treatment with blockers of neuronal uptake of dopamine. Neuropharmacology. 1991;30:89-92.
16. Benmansour S, Tejani-Butt SM, Hauptmann M, Brunswick DJ. Lack of effect of high-dose cocaine on monoamine uptake sites in rat brain measured by quantitative autoradiography. Psychopharmacology. 1992;106:459-462.
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
18. Tork I, Hornung JP. The dopamine system. In: Paxinos G, ed. The Human Nervous System. New York, NY: Academic Press; 1990:1001-1022.
19. McLaughlin DP, Little KY, Lopez JP, Watson SJ. Expression of serotonin transporter mRNA in human brainstem raphe nuclei. Neuropsychopharmacology. 1996; 15:523-529.
20. Little KY, McLaughlin DP, Ranc J, Gilmore J, Lopez JF, Watson SJ, Carroll FI, Butts JD. Serotonin transporter binding sites and mRNA levels in depressed persons committing suicide. Biol Psychiatry. 1997;41:1156-1164.
21. van Domburg PHMF, ten Donkelaar HJ. The human substantia nigra and ventral tegmental area: a neuroanatomical study with notes on aging and aging diseases. Adv Anat Embryol Cell Biol. 1991;121:1-132.
22. Koob GF, Goeders N. Neuroanatomical substrates of drug self-administration. In: Liebman JM, Cooper SJ, eds. Neuropharmacological Basis of Reward. New York, NY: Oxford University Press Inc; 1989:214-264.
23. Stellar JR, Stellar E. The Neurobiology of Motivation and Reward. New York, NY: Springer-Verlag NY Inc; 1985:166-180.
24. Danielson PE, Forss-Petter S, Brow MA, Calavetta L, Douglass J, Milner RJ, Sutcliffe JG. p1B15: a cDNA clone of the rat mRNA encoding cyclophilin. DNA. 1988; 7:261-267.
25. Kosten TR, Malison R, Wallace D. Neuropsychological abnormalities in cocaine abusers: possible correlates with SPECT neural imaging. NIDA Res Monogr. 1996; 163:175-192.
26. Volkow ND, Wang GJ, Fowler JS, Logan J, Hitzemann R, Gatley SJ, MacGregor RR, Wolf AP. Cocaine uptake is decreased in the brain of detoxified cocaine abusers. Neuropsychopharmacology. 1996;14:159-168.
27. Xia Y, Goebel DJ, Kapatos G, Bannon MJ. Quantitation of rat dopamine transporter mRNA: effects of cocaine treatment and withdrawal. J Neurochem. 1992; 59:1179-1182.
28. Letchworth SR, Daunais JB, Hedgecock AA, Porrino LJ. Effects of chronic cocaine administration on dopamine transporter mRNA and protein in the rat. Brain Res. 1997;750:214-222.
29. Cerruti C, Pilotte NS, Uhl G, Kuhar MJ. Reduction in dopamine transporter mRNA after cessation of repeated cocaine administration. Brain Res Mol Brain Res. 1994; 22:132-138.
30. Staley JK, Segal DM, Heilman CJ, Levey AI, Mash DC. Quantitation of dopamine transporter proteins in cocaine fatalities using immunological approaches. Soc Neurosci Abstr. 1995;21:721.
31. 11C]dihydrotetrabenazine and positron emission tomography. Ann Neurol. In press.
32. Tiihonen J, Kuikka J, Bergstrom K, Hakola P, Karhu J, Ryynanen OP, Fohr J. Altered striatal dopamine re-uptake site densities in habitually violent and non-violent alcoholics. Nat Med. 1995;1:654-657.
33. Volkow ND, Wang GJ, Fowler JS, Logan J, Hitzemann R, Ding YS, Pappas N, Shea C, Piscani K. Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol Clin Exp Res. 1996;20:1594-1598.
34. Little KY, McLaughlin DP, Zhang L, Livermore CS, Dalack GW, McFinton PR, Del Proposto ZS, Hill E, Cassin BJ, Watson SJ, Cook EH. Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Am J Psychiatry. 1998;155:207-213.